Rieves D - Search Results

1

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Jamali F, Lemery S, Ayalew K, Robottom S, Robie-Suh K, Rieves D, Pazdur R. Jamali F, et al. Among authors: rieves d. Oncology (Williston Park). 2009 Jul;23(8):704-9. Oncology (Williston Park). 2009. PMID: 19711585 Free article. Clinical Trial.

2

Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis.

Shashaty G, Frankewich R, Chakraborti T, Choudary J, Al-Fayoumi S, Kacuba A, Castillo S, Robie-Suh K, Rieves D, Weiss K, Pazdur R. Shashaty G, et al. Among authors: rieves d. Oncology (Williston Park). 2006 Dec;20(14):1799-1806, 1811; discussion 1811-13, 1817. Oncology (Williston Park). 2006. PMID: 17263129 Free article. Clinical Trial.

3

Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Dmytrijuk A, Robie-Suh K, Rieves D, Pazdur R. Dmytrijuk A, et al. Among authors: rieves d. Oncology (Williston Park). 2009 Nov 30;23(13):1171-7. Oncology (Williston Park). 2009. PMID: 20043468

4

FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Dmytrijuk A, Robie-Suh K, Cohen MH, Rieves D, Weiss K, Pazdur R. Dmytrijuk A, et al. Among authors: rieves d. Oncologist. 2008 Sep;13(9):993-1000. doi: 10.1634/theoncologist.2008-0086. Epub 2008 Sep 10. Oncologist. 2008. PMID: 18784156 Free article. Clinical Trial.

5

FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.

Lu M, Cohen MH, Rieves D, Pazdur R. Lu M, et al. Among authors: rieves d. Am J Hematol. 2010 May;85(5):315-9. doi: 10.1002/ajh.21656. Am J Hematol. 2010. PMID: 20201089 Free article. Clinical Trial.

6

Efficacy considerations for U.S. Food and Drug Administration approval of diagnostic radiopharmaceuticals.

Gorovets A, Marzella L, Rieves D, Yang L. Gorovets A, et al. Among authors: rieves d. J Nucl Med. 2013 Aug;54(8):1479-84. doi: 10.2967/jnumed.112.117804. Epub 2013 Jun 7. J Nucl Med. 2013. PMID: 23749997 Free article.

7

Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.

Yang L, Krefting I, Gorovets A, Marzella L, Kaiser J, Boucher R, Rieves D. Yang L, et al. Among authors: rieves d. Radiology. 2012 Oct;265(1):248-53. doi: 10.1148/radiol.12112783. Epub 2012 Aug 24. Radiology. 2012. PMID: 22923714

8

Brain amyloid imaging--FDA approval of florbetapir F18 injection.

Yang L, Rieves D, Ganley C. Yang L, et al. Among authors: rieves d. N Engl J Med. 2012 Sep 6;367(10):885-7. doi: 10.1056/NEJMp1208061. N Engl J Med. 2012. PMID: 22931256 Free article. No abstract available.

9

The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents.

Rieves D, Jacobs P. Rieves D, et al. J Nucl Med. 2016 Dec;57(12):2022-2026. doi: 10.2967/jnumed.116.178814. Epub 2016 Jul 21. J Nucl Med. 2016. PMID: 27445294 Free PMC article.

10

Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.

Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, Bouvet M, Brigman BE, Colson YL, DeMeester SR, Gurtner GC, Ishizawa T, Jacobs PM, Keereweer S, Liao JC, Nguyen QT, Olson JM, Paulsen KD, Rieves D, Sumer BD, Tweedle MF, Vahrmeijer AL, Weichert JP, Wilson BC, Zenn MR, Zinn KR, van Dam GM. Rosenthal EL, et al. Among authors: rieves d. J Nucl Med. 2016 Jan;57(1):144-50. doi: 10.2967/jnumed.115.158915. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page